88 related articles for article (PubMed ID: 11416297)
1. Permanent Cardiac Pacing in the Elderly Patient: Is Selection of the Pacing Mode Important?
Barold SS
Am J Geriatr Cardiol; 1993 Nov; 2(6):12-29. PubMed ID: 11416297
[TBL] [Abstract][Full Text] [Related]
2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
3. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST).
Link MS; Hellkamp AS; Estes NA; Orav EJ; Ellenbogen KA; Ibrahim B; Greenspon A; Rizo-Patron C; Goldman L; Lee KL; Lamas GA;
J Am Coll Cardiol; 2004 Jun; 43(11):2066-71. PubMed ID: 15172414
[TBL] [Abstract][Full Text] [Related]
4. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation.
Höijer CJ; Brandt J; Willenheimer R; Juul-Möller S; Boström PA
Eur Heart J; 2002 Mar; 23(6):490-7. PubMed ID: 11863352
[TBL] [Abstract][Full Text] [Related]
5. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy.
Deniz HB; Caro JJ; Ward A; Moller J; Malik F
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):43-50. PubMed ID: 18268418
[TBL] [Abstract][Full Text] [Related]
6. Elderly and patients with sick sinus syndrome have lower chances for appropriate pacemaker mode selection, according to the Polish Cardiac Society recommendations -- a single-centre retrospective analysis.
Rudziński T; Ciesielczyk M; Religa W; Zebrowski M; Bednarkiewicz Z; Krzemińska-Pakuła M
Kardiol Pol; 2006 Apr; 64(4):391-5; discussion 396. PubMed ID: 16699984
[TBL] [Abstract][Full Text] [Related]
7. The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients.
Lamas GA; Lee K; Sweeney M; Leon A; Yee R; Ellenbogen K; Greer S; Wilber D; Silverman R; Marinchak R; Bernstein R; Mittleman RS; Lieberman EH; Sullivan C; Zorn L; Flaker G; Schron E; Orav EJ; Goldman L
Am Heart J; 2000 Oct; 140(4):541-51. PubMed ID: 11011325
[TBL] [Abstract][Full Text] [Related]
8. Permanent Cardiac Pacing in Octogenarians.
Rosenheck S; Geist M; Weiss A; Hasin Y; Weiss TA; Gotsman MS
Am J Geriatr Cardiol; 1995 Nov; 4(6):42-47. PubMed ID: 11416354
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation.
Sielski J; Janion M; Gawor Z
Kardiol Pol; 2005 Mar; 62(3):202-9; discussion 210. PubMed ID: 15830014
[TBL] [Abstract][Full Text] [Related]
10. Atrial pacing should be used more frequently in sinus node disease.
Tripp IG; Armstrong GP; Stewart JT; Hood MA; Smith WM
Pacing Clin Electrophysiol; 2005 Apr; 28(4):291-4. PubMed ID: 15826261
[TBL] [Abstract][Full Text] [Related]
11. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ;
Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388
[TBL] [Abstract][Full Text] [Related]
12. Single chamber ventricular compared with dual chamber pacing: a review.
Wong GC; Hadjis T
Can J Cardiol; 2002 Mar; 18(3):301-7. PubMed ID: 11907619
[TBL] [Abstract][Full Text] [Related]
13. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
14. AAIsafeR limits ventricular pacing in unselected patients.
Pioger G; Leny G; Nitzsché R; Ripart A
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S66-70. PubMed ID: 17302721
[TBL] [Abstract][Full Text] [Related]
15. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
16. [Pacing mode influence on morbidity and mortality].
Roguin A; Amikam S
Harefuah; 2001 Nov; 140(11):1084-6, 1116. PubMed ID: 11759387
[TBL] [Abstract][Full Text] [Related]
17. Single chamber atrial pacing: a realistic option in sinus node disease: a long-term follow-up study of 213 patients.
Höijer CJ; Höglund P; Schüller H; Brandt J
Pacing Clin Electrophysiol; 2007 Jun; 30(6):740-7. PubMed ID: 17547606
[TBL] [Abstract][Full Text] [Related]
18. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
[TBL] [Abstract][Full Text] [Related]
19. [Incidence and risk indicators of thromboembolism during the acute phase of single chamber ventricular pacing].
Hayashi Y; Ikeda U; Asai Y; Shimada K
J Cardiol; 2003 Sep; 42(3):103-9. PubMed ID: 14526659
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST).
Fleischmann KE; Orav EJ; Lamas GA; Mangione CM; Schron EB; Lee KL; Goldman L;
Am Heart J; 2009 Jul; 158(1):78-83.e2. PubMed ID: 19540395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
